These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2008-007058-36||A Phase III Study of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor AEGR-733 in Patients with Homozygous Familial Hypercholesterolemia on Current Lipid-lowering Therapy||2011-10-13||due-trials|
|Reported results||2010-023742-79||A Phase III, Long Term, Open Label, Follow on Study of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor ‘lomitapide’ (AEGR-733) in Patients with Homozygous Familial Hypercholesterolemia||2015-02-10||due-trials|
|Exempt, with results||2012-004220-37||A randomised, double-blind, placebo-controlled, single ascending and multiple ascending dose study of the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of lomitapide in Japanes...||2013-07-22||not-yet-due|
|Exempt, with results||2013-002692-17||A Phase 1, Open-label, Crossover Study to Determine the intra-subject variability of the Pharmacokinetics of Single Oral Capsule Doses of 20 mg Lomitapide in Healthy Subjects||2013-08-23||not-yet-due|
|Other||2014-003806-33||A Phase 3, Single-arm, Open-label, International, Multi-center Study to Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients with Homozygous Familial Hypercholesterolemia on Stable Lip...||not-yet-due|